The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Cordarone X Intravenous, 150mg/3ml, Concentrate for solution for infusion or slow injection



Sanofi-Aventis Ireland Limited T/A SANOFIPA0540/142/003

Main Information

Trade NameCordarone X Intravenous, 150mg/3ml, Concentrate for solution for infusion or slow injection
Active SubstancesAmiodarone hydrochloride
Dosage FormConcentrate for solution for infusion
Licence HolderSanofi-Aventis Ireland Limited T/A SANOFI
Licence NumberPA0540/142/003

Group Information

ATC CodeC01BD Antiarrhythmics, class III
C01BD01 amiodarone

Status

License statusAuthorised
Licence Issued20/02/1984
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back